Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Instruments Considered for screening and symptom tracking for measurement based care

From: Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care

Measure

Screen or Outcome?

# of items

Time frame assessed

Self-report

References

AUDIT-C + 2

Screen

5

Past 3 months

Yes

Bradley et al. [22]

CRAFFT

Screen

9

Past year

Yes

Mitchell et al. [24]

NIDA Single Question

Screen

1

Past year

Yes

Smith et al. [25]

ASSIST-Lite

Primary & Secondary Screen

20a

Past 3 months

No

Ali et al. [26]

TAPS

Primary & Secondary Screen

4b

Past yearc

Yes

McNeely et al. [27]

DSM Checklist

Secondary Screen & Outcome

11

Variable; traditionally past year

Possible

Marsden et al. [9]

Brief Addiction Monitor (BAM)

Outcome

17

Past 30 days

Possible

Cacciola et al. [28]

Gaddy et al. [29]

Leeds Dependence Questionnaire (LDQ)

Outcome

10

Past week

Yes

Raistrick et al. [30]

Heather et al. [31]

Treatment Outcomes Profile (TOP)

Outcome

20

Past 28 days

No

Marsden et al. [32]

Treatment Effectiveness Assessment (TEA)

Outcome

4

Not specified

Yes

Ling et al. [33]

  1. aPrimary screen is 7 items; additional items asked only if primary screen for that substance is endorsed
  2. bEach item endorsed in TAPS1 leads to 2–3 follow up questions (TAPS2)
  3. cPast 3 months in TAPS2